Dr. Darryl See -- Study Of Effectiveness of Transfer Factor

TRANSFER FACTOR (Improves Immune System)
"Transfer factor is a highly concentrated immune messaging system, designed by nature to transfer critical immune programming from one individual to another." William J. Hennen, Ph.D. Biochemist

Independent Study Results

4Life Transfer Factor™ &

Transfer Factor Plus™

"Unprecedented" Immune Boosting Ability

.
Recently we reported the initial results of a groundbreaking independent study using 4Life Transfer Factor™ and Transfer Factor Plus™. Both yielded unprecedented results in a study done by the Institute of Longevity Medicine in California, a laboratory recognized for its research and expertise in measuring the ability of ingredients to significantly boost the immune system.

4Life Transfer Factor™ and Transfer Factor Plus™ were tested for their ability to increase Natural Killer Cell (NK) activity by killing live cancer cells. The research used peripheral blood mononuclear cells (PBMC) isolated from human volunteers. Test results showed that 4Life Transfer Factor™ increased the NK cell activity 103% above immune response without supplementation, more than two times higher than the next highest product. The study also showed

.
that Transfer Factor Plus™ increase the

NK cell Activity 248% above normal immune response without supplementation, or about five times higher than any of the other previously tested products.

Natural Killer Cells are an important part of our body's defense against infection and sickness. They seek and destroy infected or malignant cells and cells infected by viruses (colds/flu's).

David Lisonbee, President of 4Life Research™, in response to this research said, "These recent findings support and substantiate the reports form thousands of distributors who use Transfer Factor™ and Transfer Factor Plus™. The study also supports many other clinical experiences and studies we are familiar with. We are very pleased with the study results—they come as no surprise to us"

Noni

(Morinda

citrafolia)

15%

Aloe vera

Concentrate

(acemannan)

15%

Endocine

System

Formula

16%

Phytontrient

Formula

with Garlic

21%

Bovine

Colostrum

23%

Cordyceps

Formula

28%

Shiitake

Mushroom

42%

Echinacea

Plant

43%

Poly-

saccharide

Formula

48%

IP6

(highestof

group

previously

tested)

49%

4Life

Transfer

Factor™

104%

4Life

Transfer

Factor

Plus™

248%

5 times better than the best product tested

JEUNESSE Inc.

Institute of Longevity Medicine

PRELIMINARY REPOT (additional test results to follow)

Transfer factor testing

11-5-99

Background and rationale: 1) Cancer is the second leading cause of death in the US. The rate of nearly every type of cancer is on the rise. Despite billions of dollars in research, the mortality rate has remained nearly unchanged since the 1960's using conventional treatments such as radiation, surgery and chemotherapy. Thus, there is considerable interest in using immune modulation as an adjuvant for cancer therapy. Natural killer cells are particularly important in destroying cancer cells.

Purpose of study: 1) To determine the in vitro anti-cancer effects of Transfer Factor and Transfer Factor Plus using PBMC isolated from human volunteers and assaying the increased ability of the NK cell population to kill K562 erythroleukemic cells.

Methods: 1) PBMC killing of K 562 (erythroleukemic) cells

Results 1) Transfer Factor increased NK-cell killing by 100%

and Transfer Factor Plus by 250%

Conclusions: Transfer Factor and Transfer Factor Plus induced immune based lysis of K562 cells at a level unprecedented in the director's experience or in the known medical literature. Since NK cell function is so crucial in killing cancer cells, these products are ideal candidates for cancer adjuvant therapy. In addition, NK cells form a first line of defense against infections from viruses and certain other microorganisms. Killing assays against K562 cells have also been correlated with increased with increased activity against chronic and acute infections as well.

Darryl See MD

Director, Bioassay Laboratory

Institute of Longevity Medicine